Progress against cancer (1971–2011): how far have we come?
Open Access
- 23 September 2011
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 271 (4), 392-399
- https://doi.org/10.1111/j.1365-2796.2011.02462.x
Abstract
Tiwari AK, Roy HK (NorthShore University HealthSystem; Evanston, IL, USA). Progress against Cancer (1971–2011): how far have we come? (Historical Perspectives). J Intern Med 2012; 271: 392–399. ‘The big C’, a common euphemism for cancer, has loomed large on the collective psyche of the mankind for centuries, not least because of the relative dearth of effective treatment against this disease but its ability to relentlessly evade them and come back to haunt us. However, the struggle against cancer took a decisive turn in 1971 when a relentless campaigning by health activists eventually led to signing of the National Cancer Act in the United States, an unprecedented event in the history of diseases. As we commemorate the 40th anniversary of the signing of that historic legislation, an assessment of the progress against cancer would naturally help us understand how we have fared so far in this struggle and guide us in our efforts to re‐strategize and re‐deploy our limited resources to their best use against this immortal enemy.Keywords
This publication has 55 references indexed in Scilit:
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2011
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaNature, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosisNature, 2010
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other CancersJama-Journal Of The American Medical Association, 2009
- Mapping the Cancer GenomeScientific American, 2007
- Cancer genes and the pathways they controlNature Medicine, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJama-Journal Of The American Medical Association, 2002
- The Hallmarks of CancerCell, 2000